Rigel Recovers On 2013 Hope For Its Rheumatoid Arthritis Drug – Pharmaceutical Processing
Rigel Recovers On 2013 Hope For Its Rheumatoid Arthritis DrugPharmaceutical ProcessingR548 – the JAK3 inhibitor intended to be used to inhibit organ transplant rejection, now entering phase I trials. Shares of Rigel Pharmaceuticals may remain propped u…

